CN104524397A - Traditional Chinese medicine composition for assisted rehabilitation of stroke and preparation method of composition - Google Patents
Traditional Chinese medicine composition for assisted rehabilitation of stroke and preparation method of composition Download PDFInfo
- Publication number
- CN104524397A CN104524397A CN201510063034.XA CN201510063034A CN104524397A CN 104524397 A CN104524397 A CN 104524397A CN 201510063034 A CN201510063034 A CN 201510063034A CN 104524397 A CN104524397 A CN 104524397A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- herba
- radix
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 70
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims description 13
- 238000000034 method Methods 0.000 claims abstract description 13
- 239000002775 capsule Substances 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 230000008569 process Effects 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims description 34
- 206010008190 Cerebrovascular accident Diseases 0.000 claims description 22
- 208000006011 Stroke Diseases 0.000 claims description 22
- 239000000284 extract Substances 0.000 claims description 20
- 238000001035 drying Methods 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 241000903946 Clematidis Species 0.000 claims description 11
- 241000628997 Flos Species 0.000 claims description 11
- 239000010231 banlangen Substances 0.000 claims description 11
- 210000003038 endothelium Anatomy 0.000 claims description 11
- 210000000582 semen Anatomy 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- -1 reflux Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 5
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 229960004756 ethanol Drugs 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 235000021419 vinegar Nutrition 0.000 claims description 4
- 239000000052 vinegar Substances 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 3
- 210000003792 cranial nerve Anatomy 0.000 abstract description 3
- 230000006378 damage Effects 0.000 abstract description 3
- 206010067482 No adverse event Diseases 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 241000572565 Alpinia oxyphylla Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- 241000717675 Clerodendranthus Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 241001278833 Rosa laevigata Species 0.000 abstract 1
- 235000000661 Rosa laevigata Nutrition 0.000 abstract 1
- 241000203383 Schefflera Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 241000270295 Serpentes Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 241000270708 Testudinidae Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 18
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010013887 Dysarthria Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010004954 Birth trauma Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000019743 Cranial nerve injury Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 102000002045 Endothelin Human genes 0.000 description 1
- 108050009340 Endothelin Proteins 0.000 description 1
- 206010017585 Gait spastic Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000007072 Nerve Growth Factors Human genes 0.000 description 1
- 208000011644 Neurologic Gait disease Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000010981 drying operation Methods 0.000 description 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002461 excitatory amino acid Effects 0.000 description 1
- 239000003257 excitatory amino acid Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000007849 functional defect Effects 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 230000008449 language Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000001259 mesencephalon Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000008336 microcirculatory blood flow Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000019581 neuron apoptotic process Effects 0.000 description 1
- 230000016273 neuron death Effects 0.000 description 1
- 239000003900 neurotrophic factor Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001769 paralizing effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 108091006091 regulatory enzymes Proteins 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 208000026473 slurred speech Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for assisted rehabilitation of stroke. The traditional Chinese medicine active ingredients of the composition are prepared from the following raw materials in parts by weight: 2-10 parts of golden cypress, 5-8 parts of rhizome of swordlike atractylodes, 7-20 parts of rhizoma smilacis glabrae, 4-9 parts of plantain herb, 3-10 parts of oriental waterplantain rhizome, 5-12 parts of dandelion, 6-10 parts of honeysuckle, 3-14 parts of indigowoad root, 10-20 parts of scandent schefflera stem and leaf, 4-20 parts of weeping forsythia capsule, 6-8 parts of dwarf lilyturf tuber, 3-6 parts of cape jasmine, 2-7 parts of chicken gizzard-membrane, 8-10 parts of cherokee rose fruit, 2-5 parts of fragrant solomonseal rhizome, 7-10 parts of tortoise shell, 3-6 parts of sharpleaf galangal fruit, 1-8 parts of clematis root, 4-7 parts of cassia seed, 3-6 parts of herb of spicate clerodendranthus, 4-9 parts of fineleaf schizonepeta herb and 10-20 parts of snake gall. The traditional Chinese medicine composition is used for treating dysfunctional diseases caused by cranial nerves injuries due to stroke. In the treatment process, the traditional Chinese medicine has the advantages of convenience for taking, low price, no adverse reaction and the like, and is worthy of clinical popularization.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition and preparation method thereof, be specifically related to a kind of Chinese medicine composition for the treatment of gout and preparation method thereof.
Background technology
Apoplexy is sickness rate and the higher disease of mortality rate in world wide, is threaten one of human life and the most serious healthy disease.Its mortality rate accounts for 10% of all diseases, disability rate 50%-70%, and its midbrain infarction, namely cerebral infarction is the modal type of apoplexy.Paralytic is after hospital's treatment is survived, often leave over the obstacles such as some motions, sensation and language, after leaving hospital, family care treatment is a kind of effective good method, now, family members are if accomplish that nursing is appropriate, just can eliminate or alleviate the functional defect of patient, the disability rate of apoplexy can be reduced, disable degree, improve patient's daily life active ability.
Current topmost rehabilitation maneuver has massage suffering limb, passive exercise, active exercise, activity of daily living training etc., is aided with acupuncture, medicine foam washing, psychological counseling etc.More and more adopted oral traditional Chinese medicine preparation to carry out auxiliary treatment in recent years, and reached QI and blood regulating, relief of symptoms, promote human body recovery from illness, reduce the object of sequela.At present, the Chinese patent medicine being used for the treatment of apoplexy and sequela also existing all is in various degree taken effect slow, the defect such as curative effect is remarkable not, haves much room for improvement.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of apoplexy recovering aid scheme, comprises medicine, preparation method and application thereof.
For solving the problems of the technologies described above, Chinese medicine composition for apoplexy recovering aid of the present invention, raw material composition and the parts by weight of making described Effective Component of Chinese Medicine are, Cortex Phellodendri 2-10 part, Rhizoma Atractylodis 5-8 part, Rhizoma Smilacis Glabrae 7-20 part, Herba Plantaginis 4-9 part, Rhizoma Alismatis 3-10 part, Herba Taraxaci 5-12 part, Flos Lonicerae 6-10 part, Radix Isatidis 3-14 part, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 10-20 part, Fructus Forsythiae 4-20 part, Radix Ophiopogonis 6-8 part, Fructus Gardeniae 3-6 part, Endothelium Corneum Gigeriae Galli 2-7 part, Fructus Rosae Laevigatae 8-10 part, Rhizoma Polygonati Odorati 2-5 part, Carapax et Plastrum Testudinis 7-10 part, Fructus Alpiniae Oxyphyllae 3-6 part, Radix Clematidis 1-8 part, Semen Cassiae 4-7 part, Herba clerodendranthi spicati 3-6 part, Herba Schizonepetae 4-9 part, Fel Serpentis 10-20 part.
Preferably, the weight portion of each raw material is, Cortex Phellodendri 6 parts, Rhizoma Atractylodis 7 parts, Rhizoma Smilacis Glabrae 12 parts, Herba Plantaginis 6 parts, Rhizoma Alismatis 5 parts, Herba Taraxaci 10 parts, Flos Lonicerae 7 parts, Radix Isatidis 10 parts, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 12 parts, Fructus Forsythiae 15 parts, Radix Ophiopogonis 6 parts, Fructus Gardeniae 5 parts, Endothelium Corneum Gigeriae Galli 4 parts, Fructus Rosae Laevigatae 9 parts, Rhizoma Polygonati Odorati 4 parts, Carapax et Plastrum Testudinis 8 parts, Fructus Alpiniae Oxyphyllae 4 parts, Radix Clematidis 2 parts, Semen Cassiae 4 parts, Herba clerodendranthi spicati 5 parts, Herba Schizonepetae 5 parts, Fel Serpentis 10 parts.
Preferably, described Chinese medicine composition is the one in tablet, capsule, pill, granule or oral liquid.
The invention still further relates to the preparation method of the above-mentioned Chinese medicine composition for apoplexy recovering aid, comprise the following steps,
A. Cortex Phellodendri 2-10 part is got, Rhizoma Atractylodis 5-8 part, Rhizoma Smilacis Glabrae 7-20 part, Herba Plantaginis 4-9 part, Rhizoma Alismatis 3-10 part, Herba Taraxaci 5-12 part, Flos Lonicerae 6-10 part, is cut into small pieces, and adds the soak by water of 10-15 times of raw material weight, after water boils, slow fire boils 2-3 hour, staticly settles 12-24 hour, filters, concentrated filtrate obtains clear paste, and by gained clear paste at the temperature of 45 DEG C-55 DEG C, decompressed microwave is dry, obtain dry extract block A, for subsequent use;
B. Radix Isatidis 3-14 part is got, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 10-20 part, Fructus Forsythiae 4-20 part, Radix Ophiopogonis 6-8 part, Fructus Gardeniae 3-6 part, Endothelium Corneum Gigeriae Galli 2-7 part, Fructus Rosae Laevigatae 8-10 part, Rhizoma Polygonati Odorati 2-5 part, Carapax et Plastrum Testudinis 7-10 part, Fructus Alpiniae Oxyphyllae 3-6 part, Radix Clematidis 1-8 part, Semen Cassiae 4-7 part, pulverize, add 4-7 times of quality, mass percent concentration is 60%-70% ethanol, reflux, extract, 20-40 minute, by extracting liquid filtering, filtrate concentrate drying is become dry extract block B, for subsequent use;
C. get Herba clerodendranthi spicati 3-6 part, Herba Schizonepetae 4-9 part, is cut into small pieces, 20 minutes are cured at 100 degrees Celsius-150 degrees Celsius, fine gtinding after pulverizing, crosses 200 mesh sieves, adds 2 ~ 3 times to the white vinegar of medicated powder weight, soak 5 days, by said mixture concentrate drying, fine gtinding, crosses 800 mesh sieves, obtain powder C, for subsequent use;
D. get Fel Serpentis 10-20 part, add the distilled water of 1 times of quality, stirring is smashed, and stirs evenly, then adds 1 times of quality dehydrated alcohol, stirs, and by extracting liquid filtering, filtrate is carried out evacuation drying in 3 hours, reaches vacuum and be less than 50Pa, obtain Fel Serpentis powder;
E. dry extract block A and dry extract block B is ground into powder, adds the Fel Serpentis powder made and stir evenly, cross 500 mesh sieves, then add powder C, mixing, obtains the drug powder for apoplexy recovering aid.
The invention still further relates to the tablet made by the drug powder made according to the method described above, the Sodium Hydroxymethyl Stalcs tabletting that the medicine of described tablet made by 15 mass parts adds the starch of 1 mass parts, the hydroxypropyl emthylcellulose of 1 mass parts and 1 mass parts forms.
Improve as one, tableting processes comprises the precompressed before main pressure and main pressure, and wherein precompression is 6-10KN, and dry 2 minutes at the temperature of 50 degrees Celsius-60 degrees Celsius tabletting after precompressed, then carry out main pressure, principal pressure is 50-70KN.
The invention still further relates to the capsule made with the drug powder that said method is made, described capsule is enteric coated capsule.
The invention still further relates to the application of said medicine in preparation apoplexy recovering aid medicine.
Cortex Phellodendri has heat clearing and damp drying, and pathogenic fire purging is except steaming, and the effect of detoxification sore treatment, is used for the treatment of hyperactivity of fire caused by deficiency of YIN, night sweat hectic fever due to YIN-deficiency; Rhizoma Atractylodis cure mainly drying damp and strengthening spleen, head heavy sensation of the body pain, arthromyodynia warm nature, podomere is ached, can wind-damp dispelling, improving eyesight; Rhizoma Smilacis Glabrae detoxifies, dehumidifying, easing joint movement; Herba Plantaginis can remove pathogenic wind toxic, the liver affected by pathogenic wind heat, malicious wind dotting punch order, and swelling pain is hidden from view, and headache lacrimation, removes irritable feverish sensation of chest and heart; Rhizoma Alismatis has foster the five internal organs, physical strength profiting, plays cloudy gas, the merit of tonifying deficiency; Herba Taraxaci function heat-clearing and toxic substances removing, dispersing swelling and dissipating binds; Flos Lonicerae cures mainly disease under distension, epidemic febrile disease heating, pyretic toxicity carbuncle and ulcer; Radix Isatidis has effect of heat-clearing and toxic substances removing, is used for the treatment of temperature poison; Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) energy relaxing muscles and tendons and activating QI and blood in the collateral, circulation of qi promoting damp eliminating, cold expelling dispels the wind, eliminating dampness to stop diarrhea; The heat clearing away of Fructus Forsythiae energy, removing toxic substances, eliminating stagnation, detumescence; Radix Ophiopogonis nourishing YIN and moistening the lung reinforcing stomach reg fluid clears away heart-fire relieving restlessness; Fructus Gardeniae heat clearing away, pathogenic fire purging, removing heat from blood, controls calentura restlessness of asrhenia type and insomnia; Endothelium Corneum Gigeriae Galli removing food stagnancy is stagnant, strengthening the spleen and stomach; Fructus Rosae Laevigatae controlling nocturnal emission with astringent drugs reducing urination, relieving diarrhea with astringents; Rhizoma Polygonati Odorati nourishing YIN to relieve dryness, promoting the production of body fluid to quench thirst, Zhi Yangming epidemic febrile disease, lower rear antiperspirant goes out; Carapax et Plastrum Testudinis nourishing kidney YANG hyperactivity suppressing, replenishing kidney and strengthening bone, reinforcing the heart of nourishing blood; Fructus Alpiniae Oxyphyllae warming the spleen, warming the kidney, solid and gas; Radix Clematidis expelling wind and removing dampness, removing obstruction in the collateral to relieve pain, for rheumatic arthralgia, numb limbs and tense tendons, the contracture of muscle arteries and veins, joint stuffiness, bone is choked with sobs larynx; Semen Cassiae liver heat removing and eyesight improving, loosening bowel to relieve constipation, controls the many tear of photophobia, has a headache dizzy, poor vision; Herba clerodendranthi spicati has more antibacterial, antiinflammation, renal tubules can be made to destroy alleviate, messangial cell structural lesions reduces, complete glomerule number increases, protection and improvement result is had to the damage of nephridial tissue, glomerular filtration and kidney circulation volume can be increased, promote the eliminating of toxic metabolite, reduce blood uric acid in body; The main cold and heat of Herba Schizonepetae, scrofula, the raw skin ulcer of scrofula, broken knot gather qi together, lower blood stasis, except arthralgia chiefly caused by damp pathogen; Fel Serpentis has expelling wind and removing dampness, refrigerant improving eyesight, detoxifies and go effect of miliaria; The nervous system of adjustable benefit people, hormonal system and immune system, delay body aging.
Full side plays altogether and tonifies Qi of the kidney, tendons relaxing and meridians dredging, promotes nerve repair function, is used for the treatment of the functional disorder disease that Cranial nerve injury as birth trauma that apoplexy causes causes.Medicine goes directly disease institute, and play a role fast, few side effects, has powerful promoting blood circulation to remove obstruction in the collateral effect, can improve perineural blood circulation and body fluid circulatory fast, improve the blood circulation of nervus centralis, contribute to rehabilitation.Modern pharmacology also confirms that more than Chinese medicine has to be improved blood circulation, diminishes inflammation, regulatory enzyme change in organization, reduce Endothelin, reduce neuronal cell death and apoptosis, raising neurotrophic factor content, suppress the effects such as excitatory amino acid cytotoxicity, the microcirculatory blood flow around pathological changes cranial nerve can be made to increase, capillary open increased number, improves ischemic hypoxia state; Wherein the effect such as antiinflammatory, anti-stress, enhancing immunologic function then can suppress the inflammatory of local to change, and alleviates edema, alleviates neural pressurized situation, and improve the pathological change of cranial nerve, promote neurological functional recovery.In therapeutic process, Chinese medicine has taking convenience, cheap, and the advantage such as have no adverse reaction, and clinic is promoted.
Clinical efficacy is summed up
One, the physical data of subjects
According to the disease of tcm Standardization of diagnosis and curative effect that State Administration of Traditional Chinese Medicine announces, carry out Selecting research object, adopts pharmaceutical composition of the present invention to treat standard compliant 208 routine patients altogether, wherein man 106 example, female 102 is routine, the age be 44-68 year, 56.7 years old mean age.
Patient is divided into treatment group and matched group two groups at random, treatment group 104 example, wherein male 53 example, women 51 example, 56.2 years old mean age, matched group 104 example, wherein male 53 example, women 51 example, 57.2 years old mean age.The course of disease, the degrees of symptoms for the treatment of group and matched group two groups of cases are basically identical, two groups of patient's same degree all participated in massage suffering limb, passive exercise, active exercise, activity of daily living training etc., without significant difference, there is comparability.
Two, medicament selection
Treatment group uses the drug powder treatment prepared by embodiment 2, oral, capsule one time 2, tablet two panels, and 3 times on the one, warm water delivery service after meal 15 days is a course for the treatment of, treats 6 courses for the treatment of altogether.Matched group takes placebo.
Three, efficacy determination
Treat evaluation criteria as follows with reference to the diagnoses and treatment standard formulation of State Administration of Traditional Chinese Medicine, daily life active ability is divided into good, in, differ from three grades:
Good: to have slight dysfunction, the daily routines of energy complete independently part, need part to help;
In: there is moderate dysfunction, need to help greatly to complete activities of daily living;
Difference: have severe dysfunction, most of activities of daily living can not complete or need other people to attend.
Four, clinical observation result
After the treatment of 6 courses for the treatment of, the clinical observation on the therapeutic effect result of the test of traditional Chinese medicine composition for treating apoplexy of the present invention
Number of cases | Good | In | Difference | |
Treatment group | 104 | 51 | 28 | 25 |
Matched group | 104 | 32 | 35 | 37 |
Clinical observation on the therapeutic effect result shows, two groups of patients are in the indiscriminate situation of other treatment condition, and the therapeutic effect for the treatment of group significantly will be better than the therapeutic effect of matched group; Safety observations find, do not observe any clinical adverse, show Chinese medicine composition clinical practice of the present invention safely, have no side effect.
Through this medicine of long-term taking, the patient of 90% can recover walking, and the patient limb function of 24% is recovered substantially, and 30% resumes work; And matched group 75% recovers walking, the patient limb function of 15% is recovered substantially, and 20% resumes work.Contrast recovery extent same patient in two groups, the convalescent period of taking the patient of this medicine obviously shortens.
Detailed description of the invention
Embodiment 1
Chinese medicine composition for apoplexy recovering aid of the present invention, make described Effective Component of Chinese Medicine raw material composition and parts by weight be, Cortex Phellodendri 2 parts, Rhizoma Atractylodis 6 parts, Rhizoma Smilacis Glabrae 13 parts, Herba Plantaginis 5 parts, Rhizoma Alismatis 3 parts, Herba Taraxaci 5 parts, Flos Lonicerae 10 parts, Radix Isatidis 3 parts, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 15 parts, Fructus Forsythiae 10 parts, Radix Ophiopogonis 7 parts, Fructus Gardeniae 4 parts, Endothelium Corneum Gigeriae Galli 2 parts, Fructus Rosae Laevigatae 8 parts, Rhizoma Polygonati Odorati 4 parts, Carapax et Plastrum Testudinis 8 parts, Fructus Alpiniae Oxyphyllae 7 parts, Radix Clematidis 4 parts, Semen Cassiae 4 parts, Herba clerodendranthi spicati 6 parts, Herba Schizonepetae 5 parts, Fel Serpentis 15 parts.
The preparation method of above-mentioned Chinese medicine composition, comprises the following steps,
A. Cortex Phellodendri 2 parts is got, Rhizoma Atractylodis 6 parts, Rhizoma Smilacis Glabrae 13 parts, Herba Plantaginis 5 parts, Rhizoma Alismatis 3 parts, Herba Taraxaci 5 parts, Flos Lonicerae 10 parts, carries out drying by above-mentioned medical material, is cut into small pieces, add the soak by water of 10-15 times of raw material weight, after water boils, slow fire boils 2-3 hour, staticly settles 12 hours, filter, concentrated filtrate obtains clear paste, by gained clear paste at the temperature of 45 DEG C-55 DEG C, decompressed microwave is dry, obtains dry extract block A, for subsequent use;
B. Radix Isatidis 3 parts is got, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 15 parts, Fructus Forsythiae 10 parts, Radix Ophiopogonis 7 parts, Fructus Gardeniae 4 parts, Endothelium Corneum Gigeriae Galli 2 parts, Fructus Rosae Laevigatae 8 parts, Rhizoma Polygonati Odorati 4 parts, Carapax et Plastrum Testudinis 8 parts, Fructus Alpiniae Oxyphyllae 7 parts, Radix Clematidis 4 parts, Semen Cassiae 4 parts, carries out drying by above-mentioned medical material, pulverize, add 4-7 times of quality, mass percent concentration is 60%-70% ethanol, reflux, extract, 20-40 minute, by extracting liquid filtering, filtrate concentrate drying is become dry extract block B, for subsequent use;
C. get Herba clerodendranthi spicati 6 parts, Herba Schizonepetae 5 parts, is cut into small pieces, 20 minutes are cured at 100 degrees Celsius-150 degrees Celsius, fine gtinding after pulverizing, crosses 200 mesh sieves, adds 2 ~ 3 times to the white vinegar of medicated powder weight, soak 5 days, by said mixture concentrate drying, fine gtinding, crosses 800 mesh sieves, obtain powder C, for subsequent use;
D. get Fel Serpentis 15 parts, add the distilled water of 1 times of quality, stirring is smashed, and stirs evenly, then adds 1 times of quality dehydrated alcohol, stirs, and by extracting liquid filtering, filtrate is carried out evacuation drying in 3 hours, reaches vacuum and be less than 50Pa, obtain Fel Serpentis powder;
E. dry extract block A and dry extract block B is ground into powder, adds the Fel Serpentis powder made and stir evenly, cross 500 mesh sieves, then add powder C, mixing, obtains the drug powder for apoplexy recovering aid.
Embodiment 2
Chinese medicine composition for apoplexy recovering aid of the present invention, make described Effective Component of Chinese Medicine raw material composition and parts by weight be, Cortex Phellodendri 6 parts, Rhizoma Atractylodis 7 parts, Rhizoma Smilacis Glabrae 12 parts, Herba Plantaginis 6 parts, Rhizoma Alismatis 5 parts, Herba Taraxaci 10 parts, Flos Lonicerae 7 parts, Radix Isatidis 10 parts, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 12 parts, Fructus Forsythiae 15 parts, Radix Ophiopogonis 6 parts, Fructus Gardeniae 5 parts, Endothelium Corneum Gigeriae Galli 4 parts, Fructus Rosae Laevigatae 9 parts, Rhizoma Polygonati Odorati 4 parts, Carapax et Plastrum Testudinis 8 parts, Fructus Alpiniae Oxyphyllae 4 parts, Radix Clematidis 2 parts, Semen Cassiae 4 parts, Herba clerodendranthi spicati 5 parts, Herba Schizonepetae 5 parts, Fel Serpentis 10 parts.
The preparation method of above-mentioned Chinese medicine composition, comprises the following steps,
A. Cortex Phellodendri 6 parts is got, Rhizoma Atractylodis 7 parts, Rhizoma Smilacis Glabrae 12 parts, Herba Plantaginis 6 parts, Rhizoma Alismatis 5 parts, Herba Taraxaci 10 parts, Flos Lonicerae 7 parts, carries out drying by above-mentioned medical material, is cut into small pieces, add the soak by water of 10-15 times of raw material weight, after water boils, slow fire boils 2-3 hour, staticly settles 12-24 hour, filter, concentrated filtrate obtains clear paste, by gained clear paste at the temperature of 45 DEG C-55 DEG C, decompressed microwave is dry, obtains dry extract block A, for subsequent use;
B. Radix Isatidis 10 parts is got, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 12 parts, Fructus Forsythiae 15 parts, Radix Ophiopogonis 6 parts, Fructus Gardeniae 5 parts, Endothelium Corneum Gigeriae Galli 4 parts, Fructus Rosae Laevigatae 9 parts, Rhizoma Polygonati Odorati 4 parts, Carapax et Plastrum Testudinis 8 parts, Fructus Alpiniae Oxyphyllae 4 parts, Radix Clematidis 2 parts, Semen Cassiae 4 parts, carries out drying by above-mentioned medical material, pulverize, add 4-7 times of quality, mass percent concentration is 60%-70% ethanol, reflux, extract, 20-40 minute, by extracting liquid filtering, filtrate concentrate drying is become dry extract block B, for subsequent use;
C. get Herba clerodendranthi spicati 5 parts, Herba Schizonepetae 5 parts, is cut into small pieces, 20 minutes are cured at 100 degrees Celsius-150 degrees Celsius, fine gtinding after pulverizing, crosses 200 mesh sieves, adds 2 ~ 3 times to the white vinegar of medicated powder weight, soak 5 days, by said mixture concentrate drying, fine gtinding, crosses 800 mesh sieves, obtain powder C, for subsequent use;
D. get Fel Serpentis 10 parts, add the distilled water of 1 times of quality, stirring is smashed, and stirs evenly, then adds 1 times of quality dehydrated alcohol, stirs, and by extracting liquid filtering, filtrate is carried out evacuation drying in 3 hours, reaches vacuum and be less than 50Pa, obtain Fel Serpentis powder;
E. dry extract block A and dry extract block B is ground into powder, adds the Fel Serpentis powder made and stir evenly, cross 500 mesh sieves, then add powder C, mixing, obtains the drug powder for apoplexy recovering aid.
The invention still further relates to the tablet made by the drug powder made according to the method described above, the medicine got made by 15 mass parts adds the Sodium Hydroxymethyl Stalcs of the starch of 1 mass parts, the hydroxypropyl emthylcellulose of 1 mass parts and 1 mass parts, tabletting after mixing.Tableting processes is divided into two steps, comprises the precompressed before main pressure and main pressure, first carries out precompressed with the pressure of 6-10KN, and after molding, tabletting is dried 2 minutes at the temperature of 50 degrees Celsius-60 degrees Celsius, then carries out main pressure, and principal pressure is 50-70KN.The tablet adopting this tabletting processing mode to suppress can be that the hardness of tablet is moderate, is conducive to discharging air in powder, and reduce sliver, obtained flap-type outward appearance is good.In view of the complicated component of this medicine, the drying operation in the middle of twice tabletting, can make the humidity of tablet reduce, and increases the shelf-life of tablet.
The capsule that the drug powder that said method obtains also is made.Find through test, the gastric solubility preparation effect of this medicine is not as enteric coated preparation, and reason may be effective ingredient easy degeneration under the effect of hydrochloric acid of medicine, and gastric acid damages active component.Therefore the enteric coated capsule adopted need possess not disintegrate in 2 hours in the hydrochloric acid solution of 0.1mol/L, PH=1, and the effect of whole stripping within 40 minutes in small intestinal.
Model case is illustrated
1. Lee so-and-so, female, 61 years old, people from Jiaozhou City of Shandong Province, there is dysphagia suddenly in patient, right side limb activity is ineffective, can not stand alone, walk, companion's slurred speech, no headache, vomiting, the symptom such as to can't take care of oneself.The colleague carrying out rehabilitation takes this medicine, and through two courses for the treatment of, status of patient has had and is clearly better, and after five courses for the treatment of, patient can walk, and in slight hemiplegic gait, lamprophonia, life is taken care of oneself completely.
2. Zhang, man, 52 years old, people from Jiaozhou City of Shandong Province.Left half cool skin of patient, imperception, gatism, inarticulateness of speaking, cannot walk.The colleague carrying out rehabilitation takes this medicine, and through two courses for the treatment of, the left half body of patient starts there is consciousness, after three courses for the treatment of of taking medicine, left half body body temperature is normal, and defecation not incontinence, can walk about when there being support, take medicine after 6 courses for the treatment of, can walk about voluntarily, life can be taken care of oneself substantially.
3. Hu, man, 65 years old, people from Jimo City of Shandong Province, the paralysis for the treatment of front right half body, from face until foot does not have consciousness, can not have a meal, can not speak, after taking medicine three days, right half body has worm to climb sensation, start to regain consciousness, after two weeks of taking medicine, right half body can move, and can have a meal; After taking medicine one month, can sit up; Taking medicine can leave the bed after two months walks about, and hands can take thing, and life can be taken care of oneself substantially.After adhere to taking medicine, application returns to one's perfect health, and can do housework.
4. gold, female, 55 years old, people from Zhucheng, Shandong Province, before treatment, left hand can not take thing, and left foot can not lifted on foot, walks unstable.After taking medicine one month, left hand can pick up large piece article, and fine movement is slightly inconvenient, and left foot can lift; After taking medicine two months, left hand can do fine movement, and basic recovery of walking normally, can normally work.
Claims (8)
1. the Chinese medicine composition for apoplexy recovering aid, it is characterized in that: raw material composition and the parts by weight of making described Effective Component of Chinese Medicine are, Cortex Phellodendri 2-10 part, Rhizoma Atractylodis 5-8 part, Rhizoma Smilacis Glabrae 7-20 part, Herba Plantaginis 4-9 part, Rhizoma Alismatis 3-10 part, Herba Taraxaci 5-12 part, Flos Lonicerae 6-10 part, Radix Isatidis 3-14 part, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 10-20 part, Fructus Forsythiae 4-20 part, Radix Ophiopogonis 6-8 part, Fructus Gardeniae 3-6 part, Endothelium Corneum Gigeriae Galli 2-7 part, Fructus Rosae Laevigatae 8-10 part, Rhizoma Polygonati Odorati 2-5 part, Carapax et Plastrum Testudinis 7-10 part, Fructus Alpiniae Oxyphyllae 3-6 part, Radix Clematidis 1-8 part, Semen Cassiae 4-7 part, Herba clerodendranthi spicati 3-6 part, Herba Schizonepetae 4-9 part, Fel Serpentis 10-20 part.
2. according to the Chinese medicine composition for apoplexy recovering aid according to claim 1, it is characterized in that: the weight portion of each raw material is, Cortex Phellodendri 6 parts, Rhizoma Atractylodis 7 parts, Rhizoma Smilacis Glabrae 12 parts, Herba Plantaginis 6 parts, Rhizoma Alismatis 5 parts, Herba Taraxaci 10 parts, Flos Lonicerae 7 parts, Radix Isatidis 10 parts, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 12 parts, Fructus Forsythiae 15 parts, Radix Ophiopogonis 6 parts, Fructus Gardeniae 5 parts, Endothelium Corneum Gigeriae Galli 4 parts, Fructus Rosae Laevigatae 9 parts, Rhizoma Polygonati Odorati 4 parts, Carapax et Plastrum Testudinis 8 parts, Fructus Alpiniae Oxyphyllae 4 parts, Radix Clematidis 2 parts, Semen Cassiae 4 parts, Herba clerodendranthi spicati 5 parts, Herba Schizonepetae 5 parts, Fel Serpentis 10 parts.
3. according to the Chinese medicine composition for apoplexy recovering aid in claim 2 described in any one, it is characterized in that: described Chinese medicine composition is the one in tablet, capsule, pill, granule or oral liquid.
4. prepare a method for the Chinese medicine composition for apoplexy recovering aid described in claim 1, it is characterized in that: comprise the following steps,
A. Cortex Phellodendri 2-10 part is got, Rhizoma Atractylodis 5-8 part, Rhizoma Smilacis Glabrae 7-20 part, Herba Plantaginis 4-9 part, Rhizoma Alismatis 3-10 part, Herba Taraxaci 5-12 part, Flos Lonicerae 6-10 part, is cut into small pieces, and adds the soak by water of 10-15 times of raw material weight, after water boils, slow fire boils 2-3 hour, staticly settles 12-24 hour, filters, concentrated filtrate obtains clear paste, and by gained clear paste at the temperature of 45 DEG C-55 DEG C, decompressed microwave is dry, obtain dry extract block A, for subsequent use;
B. Radix Isatidis 3-14 part is got, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 10-20 part, Fructus Forsythiae 4-20 part, Radix Ophiopogonis 6-8 part, Fructus Gardeniae 3-6 part, Endothelium Corneum Gigeriae Galli 2-7 part, Fructus Rosae Laevigatae 8-10 part, Rhizoma Polygonati Odorati 2-5 part, Carapax et Plastrum Testudinis 7-10 part, Fructus Alpiniae Oxyphyllae 3-6 part, Radix Clematidis 1-8 part, Semen Cassiae 4-7 part, pulverize, add 4-7 times of quality, mass percent concentration is 60%-70% ethanol, reflux, extract, 20-40 minute, by extracting liquid filtering, filtrate concentrate drying is become dry extract block B, for subsequent use;
C. get Herba clerodendranthi spicati 3-6 part, Herba Schizonepetae 4-9 part, is cut into small pieces, 20 minutes are cured at 100 degrees Celsius-150 degrees Celsius, fine gtinding after pulverizing, crosses 200 mesh sieves, adds 2 ~ 3 times to the white vinegar of medicated powder weight, soak 5 days, by said mixture concentrate drying, fine gtinding, crosses 800 mesh sieves, obtain powder C, for subsequent use;
D. get Fel Serpentis 10-20 part, add the distilled water of 1 times of quality, stirring is smashed, and stirs evenly, then adds 1 times of quality dehydrated alcohol, stirs, and by extracting liquid filtering, filtrate is carried out evacuation drying in 3 hours, reaches vacuum and be less than 50Pa, obtain Fel Serpentis powder;
E. dry extract block A and dry extract block B is ground into powder, adds the Fel Serpentis powder made and stir evenly, cross 500 mesh sieves, then add powder C, mixing, obtains the drug powder for apoplexy recovering aid.
5. with the tablet that the medicine that method in claim 4 is made is made, it is characterized in that: the Sodium Hydroxymethyl Stalcs tabletting that the medicine of described tablet made by 15 mass parts adds the starch of 1 mass parts, the hydroxypropyl emthylcellulose of 1 mass parts and 1 mass parts forms.
6. prepare the method for tablet described in claim 5 for one kind, it is characterized in that: tableting processes comprises the precompressed before main pressure and main pressure, and wherein precompression is 6-10KN, after precompressed, tabletting is dried 2 minutes at the temperature of 50 degrees Celsius-60 degrees Celsius, carry out main pressure again, principal pressure is 50-70KN.
7. with the capsule that the medicine that method in claim 4 is made is made, it is characterized in that: described capsule is enteric coated capsule.
8. the application of the arbitrary pharmaceutical composition described in claim 1 ~ 7 in preparation apoplexy recovering aid medicine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510063034.XA CN104524397A (en) | 2015-02-08 | 2015-02-08 | Traditional Chinese medicine composition for assisted rehabilitation of stroke and preparation method of composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510063034.XA CN104524397A (en) | 2015-02-08 | 2015-02-08 | Traditional Chinese medicine composition for assisted rehabilitation of stroke and preparation method of composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104524397A true CN104524397A (en) | 2015-04-22 |
Family
ID=52840153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510063034.XA Pending CN104524397A (en) | 2015-02-08 | 2015-02-08 | Traditional Chinese medicine composition for assisted rehabilitation of stroke and preparation method of composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104524397A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105535454A (en) * | 2015-12-29 | 2016-05-04 | 张林涛 | Medicine for treating diastolic cardiac dysfunction |
CN106215051A (en) * | 2016-08-31 | 2016-12-14 | 王东宝 | A kind of Chinese and Western compound medicine treating peripheral nerve injury and preparation method |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1286108A (en) * | 1999-09-01 | 2001-03-07 | 陈大明 | Chinese medicine for treating apoplexy |
-
2015
- 2015-02-08 CN CN201510063034.XA patent/CN104524397A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1286108A (en) * | 1999-09-01 | 2001-03-07 | 陈大明 | Chinese medicine for treating apoplexy |
Non-Patent Citations (3)
Title |
---|
李俊: "中风后遗两便失禁的治疗体会", 《上海中医药杂志》 * |
郑国庆等: "风药治血与中风病证治", 《中国医药学报》 * |
郭明玉: "郭鹏琪运用三痹汤加减治疗中风后遗症68例", 《福建中医药》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105535454A (en) * | 2015-12-29 | 2016-05-04 | 张林涛 | Medicine for treating diastolic cardiac dysfunction |
CN106215051A (en) * | 2016-08-31 | 2016-12-14 | 王东宝 | A kind of Chinese and Western compound medicine treating peripheral nerve injury and preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091258B (en) | Chinese medicinal composition for dispelling scars and preparation method thereof | |
CN103656238B (en) | A kind of Chinese medicine composition for the treatment of rheumatic osteopathia | |
CN101804166B (en) | Traditional Chinese medicine composition for treating dermatitis and eczema of infants | |
CN101810685B (en) | Chinese medicinal composition for treating gonitis and preparation method thereof | |
CN103768567B (en) | A kind of black plaster and preparation method thereof | |
CN103520572A (en) | Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition | |
CN102166278B (en) | Chinese medicinal composition for treating pediatric rheumatoid arthritis and preparation method thereof | |
CN104069474A (en) | Traditional Chinese medicine composition for treating seborrheic alopecia and preparation method thereof | |
CN1977899B (en) | Medicine for treating rheumatoid arthritis | |
CN104524397A (en) | Traditional Chinese medicine composition for assisted rehabilitation of stroke and preparation method of composition | |
CN104825956A (en) | Medicine for preventing and treating stroke and recovering muscles, bones and joints | |
CN101342331B (en) | Traditional Chinese medicine for treating pulmonitis and upper respiratory tract infection | |
CN104666799A (en) | Blood circulation activating and blood stasis removing medicinal liquor for soft tissue injury and preparation method of medicinal liqour | |
CN104784459A (en) | Traditional Chinese medicine preparation for treating dizziness caused by neurasthenia and preparation method thereof | |
CN103751467A (en) | Traditional Chinese medicine composition for treating lumbar and back myofascitis and preparation method thereof | |
CN106729443A (en) | A kind of Chinese medicine composition for swelling and pain relieving and preparation method thereof | |
CN105106786A (en) | Traditional Chinese medicine composition capable of dredging collaterals and relaxing muscles as well as preparation and production method of composition | |
CN101380425A (en) | Arthrosis pill and production method thereof | |
CN104922595A (en) | Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof | |
CN105168947A (en) | Traditional Chinese medicine composition for treating hypochondriac pain with syndrome of liver-yin deficiency | |
CN105412395A (en) | Traditional Chinese medicine composition for treating hyperostosis and preparation method thereof | |
CN104800604A (en) | Traditional Chinese medicine formula for treating Parkinsonism | |
CN104906517A (en) | Medicine for treating hemiplegia caused by hypertension | |
CN104288636A (en) | Pharmaceutical composition and application thereof | |
CN104027789A (en) | Traditional Chinese medicine composition for treating cold retardation type jaundice of newborn babies and preparing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150422 |
|
WD01 | Invention patent application deemed withdrawn after publication |